Implementation and utilization of the molecular tumor board to guide precision medicine.

ABSTRACT:

Background

With rapid advances in genomic medicine, the complexity of delivering precision medicine to oncology patients across a university health system demanded the creation of a Molecular Tumor Board (MTB) for patient selection and assessment of treatment options. The objective of this report is to analyze our progress to date and discuss the importance of the MTB in the implementation of personalized medicine.

Materials and methods

Patients were reviewed in the MTB for appropriateness for comprehensive next generation sequencing (NGS) cancer gene set testing based on set criteria that were in place. Because profiling of stage IV lung cancer, colon cancer, and melanoma cancers were standard of care, these cancer types were excluded from this process. We subsequently anal

SUBMITTER: Harada S 

PROVIDER: S-EPMC5593688 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature